Market Overview

Deutsche Bank Upgrades ResMed to Buy

Deutsche Bank has upgraded ResMed (NYSE: RMD) from Hold to Buy and has raised the price target from $31 to $32.

Posted-In: Deutsche BankUpgrades Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (RMD)

Around the Web, We're Loving...

Get Benzinga's Newsletters